CLINICAL_TRIALS
trial_result
· 2008-06-06
Clinical Trial Update: Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial [Phase 1, Phase 2]
Summary
A Phase 1/2 double-blind trial evaluating whether zinc reduces hyperbilirubinemia in high-risk neonates has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: All India Institute of Medical Sciences | Conditions: Neonatal Jaundice | Phase 1, Phase 2 | Status: COMPLETED